IP Library Granted Patent US 10,953,062
Granted Patent B2
US 10,953,062 · App. 16/496,741 · Granted Mar 23, 2021

Anticancer pharmaceutical composition and application thereof

Inventors: Shouqian Li (Bijie, CN); Shouyue Li (Bijie, CN); Yu Zhou (Bijie, CN)
Assignee: GUIZHOU JIN QIAN FRUIT BIOTECHNOLOGY CO., LTD.
A61K36/738A61K9/0053A61K36/074A61K36/185A61K36/38A61K36/52A61K36/71A61K36/752A61K36/889A61K36/8988A61P35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,953,062
App. No.
16/496,741
Granted
Mar 23, 2021
Kind
B2
Abstract

The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii , 0.5-30 parts of fruits/leaves of Phyllanthus emblica , 0.5-30 parts of peel/seeds of Punica granatum , 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana , 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon , 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae , 0.1-5 parts of Lucid ganoderma , 0.1-5 parts of seeds/leaves of Moringa oleifera , 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.

Claims (6)

1. An anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits and/or leaves of Rosa roxburghii, 0.5-30 parts of fruits and/or leaves of Phyllanthus emblica, 0.5-30 parts of peel and/or seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh and/or pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp and/or peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds and/or leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis;

wherein the fruits and/or leaves of Rosa roxburghii is selected from any one of fresh Rosa roxburghii fruits, dried Rosa roxburghii fruits, fresh Rosa roxburghii leaves and dried Rosa roxburghii leaves, or any combination thereof; the fruits and/or leaves of Phyllanthus emblica is selected from any one of fresh Phyllanthus emblica fruits, dried Phyllanthus emblica fruits, fresh Phyllanthus emblica leaves and dried Phyllanthus emblica leaves, or any combination thereof; the peel and/or seeds of Punica granatum is selected from any one of fresh Punica granatum peel, dried Punica granatum peel, fresh Punica granatum seeds, and dried Punica granatum seeds, or any combination thereof; the flesh and/or pericarp of Garcinia mangostana is selected from any one of fresh Garcinia mangostana flesh, dried Garcinia mangostana flesh, fresh Garcinia mangostana pericarp and dried Garcinia mangostana pericarp, or any combination thereof; the pulp and/or peel of Citrus limon is selected from any one of fresh Citrus limon pulp, dried Citrus limon pulp, fresh Citrus limon peel and dried Citrus limon peel, or any combination thereof; and the seeds and/or leaves of Moringa oleifera is selected from any one of fresh Moringa oleifera seeds, dried Moringa oleifera seeds, fresh Moringa oleifera leaves and dried Moringa oleifera leaves, or any combination thereof; and

wherein the dosage forms of the anticancer pharmaceutical composition are tablets, capsules, pills, ointments, or liniments.

2. The composition according to claim 1 , comprising the following materials in parts by weight: 1-20 parts of fruits and/or leaves of Rosa roxburghii, 1-20 parts of fruits and/or leaves of Phyllanthus emblica, 1-20 parts of peel and/or seeds of Punica granatum, 1-20 parts of honey, 1-20 parts of flesh and/or pericarp of Garcinia mangostana, 1-20 parts of coconuts, 1-20 parts of pulp and/or peel of Citrus limon, 1-20 parts of raw walnuts, 0.2-2 parts of Rhizoma gastrodiae, 0.2-2 parts of Lucid ganoderma, 0.2-2 parts of seeds and/or leaves of Moringa oleifera, 0.01-1 part of Radix ranunculi ternati and 0.01-1 part of Rhizoma paridis.

3. A method for treating or adjunctively treating cancer, the method comprising administering (i) drugs, (ii) health food or (iii) food prepared from the anticancer pharmaceutical composition of claim 1 .

4. A method for treating or adjunctively treating cancer, the method comprising administering (i) drugs, (ii) health food or (iii) food prepared from the anticancer pharmaceutical composition of claim 2 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2021
From: LI, SHOUQIAN; LI, SHOUYUE; ZHOU, YU
To: GUIZHOU JIN QIAN FRUIT BIOTECHNOLOGY CO., LTD.
Reel/Frame 055178/0264 →
Priority Claims (1)
CN 201710184824.2 · Mar 24, 2017 · national
Continuity (1)
Related Publication 20200030401A1 · Jan 30, 2020